J&J Medical Connect
TECVAYLI®

(teclistamab-cqyv)

J&J Medical Connect

Connect with us

  • Products

This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.

TECVAYLI - Management of Neurotoxic Events

Last Updated: 10/14/2026

SUMMARY  

  • Johnson & Johnson does not recommend the use of TECVAYLI in a manner inconsistent with the approved labeling.
  • Please refer to local labeling for neurotoxicity management recommendations.
  • Consider further management per current practice guidelines or institutional guidelines.

Literature Search

A literature search of MEDLINE®, Embase®, BIOSIS Previews®, and Derwent Drug File databases (and/or other resources, including internal/external databases) topic was conducted on 09 October 2026.

Would you like to clear and leave your conversation? Message history will be lost.